Dermata Therapeutics Inc. Warrant (DRMAW)
Stock · NASDAQ · Health Care
$0.0006as of 8/17/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Industry
Biotechnology: Pharmaceutical Preparations
Dermata Therapeutics Inc. Warrant Competitors
Chosen by industry and closest market cap.
- DRMAWDermata Therapeutics Inc. Warrant$0.0006▼ 50.00%Market cap $30.2KP/E —
- BCTXZBriaCell Therapeutics Corp. Warrant expiring 2030$0.135▲ 12.31%Market cap $782.1KP/E —$0.0551$0.52
- BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.8351▼ 7.21%Market cap $1.06MP/E —$0.8303$59.4
- CDTCDT Equity Inc. Common Stock$1.69▼ 10.37%Market cap $1.81MP/E —$1.62$2,928
- MTNBMatinas Biopharma Holdings Inc. Common Stock$0.1966▼ 1.70%Market cap $1.93MP/E —$0.178$2.14
- OGENOragenics Inc. Common Stock$0.5296▼ 0.08%Market cap $2.39MP/E —$0.4801$1.45
- SBFMSunshine Biopharma Inc. Common Stock$1.16▼ 8.66%Market cap $2.48MP/E —$1.01$24.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| DRMAW Dermata Therapeutics Inc. Warrant | $30.2K | — | $0.0006 | ▼ 50.00% | |
| BCTXZ BriaCell Therapeutics Corp. Warrant expiring 2030 | $782.1K | — | $0.135 | ▲ 12.31% | $0.0551$0.52 |
| BDRX Biodexa Pharmaceuticals plc American Depositary Shs | $1.06M | — | $0.8351 | ▼ 7.21% | $0.8303$59.4 |
| CDT CDT Equity Inc. Common Stock | $1.81M | — | $1.69 | ▼ 10.37% | $1.62$2,928 |
| MTNB Matinas Biopharma Holdings Inc. Common Stock | $1.93M | — | $0.1966 | ▼ 1.70% | $0.178$2.14 |
| OGEN Oragenics Inc. Common Stock | $2.39M | — | $0.5296 | ▼ 0.08% | $0.4801$1.45 |
| SBFM Sunshine Biopharma Inc. Common Stock | $2.48M | — | $1.16 | ▼ 8.66% | $1.01$24.3 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 13.3K
- Total value held
- $14.5K
- Institutional holders
- 2
Top holders this quarter
- Unknown12.0K
- Unknown1.3K
See the full, filterable feed with live charts on the MarketWall dashboard.